Minneapolis, MN, United States of America

Paul R Barratt


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 145(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul R Barratt: Innovator in Medical Technology

Introduction

Paul R Barratt is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical technology, particularly in the development of innovative devices that enhance patient care. With a total of 2 patents to his name, Barratt's work exemplifies the intersection of engineering and medicine.

Latest Patents

One of Barratt's latest patents is a tissue opening occluder. This device comprises first and second occluder portions, each featuring a frame structure and an attachment structure to connect the two portions. The frames are designed to constrain tissue between the two portions, effectively restricting the significant passage of blood. Additionally, the frame portions may be covered by a fabric suspended from their perimeter, ensuring a secure fit. The occluder portions are conjoined at least one point on each portion, enhancing its functionality.

Career Highlights

Barratt is currently associated with Ev3 Endovascular, Inc., a company that specializes in developing innovative solutions for vascular diseases. His work at Ev3 Endovascular has allowed him to collaborate with other talented professionals in the field, further advancing medical technology.

Collaborations

Some of Barratt's coworkers include Michelle M Young and Jana F Oman. Their collective expertise contributes to the innovative environment at Ev3 Endovascular, fostering the development of groundbreaking medical devices.

Conclusion

Paul R Barratt's contributions to medical technology through his patents and work at Ev3 Endovascular highlight his commitment to improving patient outcomes. His innovative spirit continues to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…